Nucleic Acids Research, Vol 24, Issue 20 3962-3967, Copyright © 1996 by Oxford University Press
K Fukui and K Tanaka
The interactions between the intercalating agent and the three types of
abasic sites: abasic frameshift, apurinic and apyrimidinic, were
investigated. 9-amino-6-chloro-2-methoxyacridine (ACMA), whose
spectroscopic properties are strongly perturbed by the environment, was
selected as the intercalating agent. The optically pure threoninol derived
from the reduction of L-threonine was used as an artificial abasic site
mimicking the ring-opened natural ribose. In order to secure the selective
intercalation to the adjacent abasic site, ACMA and the abasic site were
connected through a tri- pentamethylene linker. These modified
oligonucleotides covalently linked to an ACMA molecule at the
internucleotide site having the same base-sequence were synthesized using
the acridine-phosphoramidites. Although all the modified oligonucleotides
lack a nucleobase at the intervening position, these double strands showed
high thermal stability. The pentamethylene linker and the apyrimidinic
systems were especially stabilized. At the same time, sharpness of the
absorption spectra and a new fluorescent band of the acridine, due to the
fixation of the environment around ACMA, were observed. Therefore, it is
concluded that the acridine binds preferentially to the apyrimidinic site
rather than the frameshift abasic site and that the surroundings of the
acridine are strictly fixed at the microenvironmental level.
ARTICLES
The acridine ring selectively intercalated into a DNA helix at various types of abasic sites: double strand formation and photophysical properties
Division of Molecular Engineering, Graduate School of Engineering, Kyoto University, Japan.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
Y. Huang, H. Okochi, B. C. H. May, G. Legname, S. B. Prusiner, L. Z. Benet, B. J. Guglielmo, and E. T. Lin QUINACRINE IS MAINLY METABOLIZED TO MONO-DESETHYL QUINACRINE BY CYP3A4/5 AND ITS BRAIN ACCUMULATION IS LIMITED BY P-GLYCOPROTEIN Drug Metab. Dispos., July 1, 2006; 34(7): 1136 - 1144. [Abstract] [Full Text] [PDF] |
||||
